AccuStem Sciences, Inc. Announces Chairman Purchase of Shares Press Release AccuStem Sciences, Inc. Announces Chairman Purchase of Shares By accustem|2022-04-28T09:00:31-07:00April 28, 2022|Press Release|
AccuStem Announces DTC Eligibility Press Release AccuStem Announces DTC Eligibility By accustem|2022-04-14T20:40:33-07:00April 14, 2022|Press Release|
AccuStem Announces Private Placement of Common Stock Press Release AccuStem Announces Private Placement of Common Stock By accustem|2022-04-05T20:54:48-07:00April 5, 2022|Press Release|
AccuStem Sciences, Inc. Announces DTC Eligibility Press Release AccuStem Sciences, Inc. Announces DTC Eligibility By accustem|2022-03-23T09:20:40-07:00March 23, 2022|Press Release|
AccuStem Sciences, Inc. Appoints New Executive Leadership Team Press Release AccuStem Sciences, Inc. Appoints New Executive Leadership Team By accustem|2022-03-23T09:23:55-07:00March 4, 2022|Press Release|
AccuStem’s StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort Press Release AccuStem’s StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort By accustem|2022-03-04T05:57:19-08:00March 1, 2022|Press Release|
Scheme of Arrangement Effective Press Release Scheme of Arrangement Effective By accustem|2022-04-04T21:29:59-07:00December 1, 2021|Press Release|
Court Sanctions the Scheme of Arrangement Press Release Court Sanctions the Scheme of Arrangement By accustem|2022-04-04T21:29:30-07:00November 26, 2021|Press Release|
Results of Shareholder Meetings Press Release Results of Shareholder Meetings By accustem|2022-04-04T21:28:44-07:00November 25, 2021|Press Release|
Accustem Scheme Document Press Release Accustem Scheme Document By accustem|2022-02-15T13:21:28-08:00November 20, 2021|Press Release|
